Skip to main content

Semaglutide Injectables & Signal Identification

Basic Details
Status
Complete
Last Updated
Tuesday, September 15, 2026
Original Posting Date
Health Outcome(s)
signal identification
Purpose
Signal Identification
Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
No
Analytic Code Link(s) (2)
Outcome Monitoring Following Semaglutide Use: A Self-Controlled Risk Interval Signal Identification Analysis Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: An Active Comparator Signal Identification Analysis
Result(s) (2)
Outcome Monitoring Following Semaglutide Use: A Self-Controlled Risk Interval Signal Identification Analysis Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: An Active Comparator Signal Identification Analysis
Related Publication(s) and/or Presentation(s) (1)
Presentation: Finding Needles in the Same Haystack: Comparing Designated Medical Event vs Untargeted Approach in Signal Identification